Skip to main content
Premium Trial:

Request an Annual Quote

In the Early Adopter Race, It's Consumers vs. Physicians

Hsien-Hsien Lei blogs about personalized medicine, kicking off the post with a reference to this Wall Street Journal story. It's a business take on the field, so you'll get such insights as: "The ultimate goal is to develop medicines tailored to patients with a particular genetic makeup or who have diseases with a particular gene variation that are more responsive to a specific treatment." (But it's the perfect article to forward to friends who don't understand this topic at all.)

In Hsien-Hsien's post, though, you'll get more insightful comments; she contends that this shift in medicine can only come about with a corresponding shift in how "consumers approach healthcare," she writes. "No one knows exactly how consumers will embrace genomics and personalized medicine when they become part of standard medical care. There is no doubt, however, that the trickle of consumer genomics will soon grow into a torrent. Are we prepared?"


The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.